Is Equillium Stock a Good Investment?
Equillium Investment Advice | EQ |
- Examine Equillium's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Equillium's leadership team and their track record. Good management can help Equillium navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Equillium's business and its evolving consumer preferences.
- Compare Equillium's performance and market position to its competitors. Analyze how Equillium is positioned in terms of product offerings, innovation, and market share.
- Check if Equillium pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Equillium's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Equillium stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Equillium is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Very Weak | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Equillium Stock
Researching Equillium's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 36.0% of the company shares are held by company insiders. The book value of Equillium was currently reported as 0.6. The company recorded a loss per share of 0.35. Equillium had not issued any dividends in recent years.
To determine if Equillium is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Equillium's research are outlined below:
| Equillium generated a negative expected return over the last 90 days | |
| Equillium has high historical volatility and very poor performance | |
| Equillium has some characteristics of a very speculative penny stock | |
| The company generated the yearly revenue of 36.08 M. Annual Net Loss to common stockholders was (13.34 M) with gross profit of 15.76 M. | |
| Equillium reports about 57.56 M in cash with (21.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.68, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Equillium has a very weak financial position based on the latest SEC disclosures | |
| Roughly 36.0% of the company shares are held by company insiders | |
| Latest headline from forbes.com: AI IQ And EQ Or The Message And The Messenger |
Equillium Quarterly Cash And Short Term Investments |
|
Equillium uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Equillium. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Equillium's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 28th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Equillium's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Equillium's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-03-24 | 2020-12-31 | -0.4 | -0.36 | 0.04 | 10 | ||
2019-05-13 | 2019-03-31 | -0.3 | -0.34 | -0.04 | 13 | ||
2020-03-26 | 2019-12-31 | -0.39 | -0.44 | -0.05 | 12 | ||
2019-11-12 | 2019-09-30 | -0.4 | -0.35 | 0.05 | 12 | ||
2023-11-08 | 2023-09-30 | -0.17 | -0.11 | 0.06 | 35 | ||
2024-05-09 | 2024-03-31 | -0.15 | -0.08 | 0.07 | 46 | ||
2023-08-09 | 2023-06-30 | -0.17 | -0.1 | 0.07 | 41 | ||
2022-05-12 | 2022-03-31 | -0.37 | -0.45 | -0.08 | 21 |
Know Equillium's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Equillium is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Equillium backward and forwards among themselves. Equillium's institutional investor refers to the entity that pools money to purchase Equillium's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Integrated Wealth Concepts Llc | 2024-03-31 | 40 K | Northern Trust Corp | 2024-03-31 | 35 K | Prudential Financial Inc | 2024-03-31 | 31.2 K | Commonwealth Equity Services Inc | 2024-03-31 | 25 K | Springbok Capital Management, Llc | 2024-03-31 | 15.5 K | Susquehanna International Group, Llp | 2024-03-31 | 14.7 K | Jane Street Group, Llc | 2023-12-31 | 12 K | Marshall Wace Asset Management Ltd | 2024-03-31 | 11.9 K | Ground Swell Capital, Llc | 2024-03-31 | 11.4 K | Decheng Capital Llc | 2024-03-31 | 4.4 M | Vanguard Group Inc | 2024-03-31 | 841.9 K |
Equillium's market capitalization trends
The company currently falls under 'Micro-Cap' category with a market capitalization of 28.2 M.Market Cap |
|
Equillium's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.26) | (0.28) | |
| Return On Capital Employed | (0.63) | (0.66) | |
| Return On Assets | (0.26) | (0.28) | |
| Return On Equity | (0.59) | (0.62) |
Determining Equillium's profitability involves analyzing its financial statements and using various financial metrics to determine if Equillium is a good buy. For example, gross profit margin measures Equillium's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Equillium's profitability and make more informed investment decisions.
The data published in Equillium's official financial statements typically reflect Equillium's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Equillium's quantitative information. For example, before you start analyzing numbers published by Equillium accountants, it's essential to understand Equillium's liquidity, profitability, and earnings quality within the context of the Biotechnology space in which it operates.
Please note, the imprecision that can be found in Equillium's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Equillium. Check Equillium's Beneish M Score to see the likelihood of Equillium's management manipulating its earnings.
Evaluate Equillium's management efficiency
Equillium has Return on Asset (ROA) of (0.1431) % which means that for every 100 dollars spent on asset, it generated a loss of $0.1431. This is way below average. Likewise, it shows a return on total equity (ROE) of (0.4817) %, which implies that it produced no returns to current stockholders. Equillium's management efficiency ratios could be used to measure how well Equillium manages its routine affairs as well as how well it operates its assets and liabilities. As of 07/26/2024, Return On Tangible Assets is likely to drop to -0.28. In addition to that, Return On Capital Employed is likely to drop to -0.66. At this time, Equillium's Total Current Liabilities is relatively stable compared to the past year. As of 07/26/2024, Liabilities And Stockholders Equity is likely to grow to about 67.5 M, while Non Current Liabilities Total is likely to drop slightly above 364.8 K.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.65 | 0.62 | |
| Tangible Book Value Per Share | 0.65 | 0.62 | |
| Enterprise Value Over EBITDA | (0.19) | (0.20) | |
| Price Book Value Ratio | 1.11 | 1.53 | |
| Enterprise Value Multiple | (0.19) | (0.20) | |
| Price Fair Value | 1.11 | 1.53 | |
| Enterprise Value | 2.7 M | 2.6 M |
The analysis of Equillium's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Equillium's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Equillium Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 1.818 |
Basic technical analysis of Equillium Stock
As of the 26th of July, Equillium shows the Variance of 41.45, mean deviation of 4.5, and Standard Deviation of 6.44. Equillium technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Equillium's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Equillium insiders, such as employees or executives, is commonly permitted as long as it does not rely on Equillium's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Equillium insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Troupin Barbara over two months ago Acquisition by Troupin Barbara of 20000 shares of Equillium at 1.43 subject to Rule 16b-3 | ||
Troupin Barbara over two months ago Insider Trading | ||
Stephen Connelly over three months ago Disposition of 8490 shares by Stephen Connelly of Equillium at 7.0842 subject to Rule 16b-3 | ||
Zedelmayer Christine over three months ago Acquisition by Zedelmayer Christine of 8334 shares of Equillium at 2.45 subject to Rule 16b-3 | ||
Joel Rothman over three months ago Acquisition by Joel Rothman of 8804 shares of Equillium subject to Rule 16b-3 | ||
Jason Keyes over six months ago Acquisition by Jason Keyes of 15000 shares of Equillium subject to Rule 16b-3 | ||
Charles McDermott over a year ago Acquisition by Charles McDermott of 24000 shares of Equillium subject to Rule 16b-3 |
Equillium's Outstanding Corporate Bonds
Equillium issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Equillium uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Equillium bonds can be classified according to their maturity, which is the date when Equillium has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US29444UBK16 Corp BondUS29444UBK16 | View | |
| US29444UBL98 Corp BondUS29444UBL98 | View | |
| US29444UBM71 Corp BondUS29444UBM71 | View | |
| US29444UBQ85 Corp BondUS29444UBQ85 | View | |
| EQUINIX INC Corp BondUS29444UBS42 | View | |
| EQIX 2 15 MAY 28 Corp BondUS29444UBR68 | View | |
| EQIX 34 15 FEB 52 Corp BondUS29444UBT25 | View | |
| EQIX 39 15 APR 32 Corp BondUS29444UBU97 | View |
Understand Equillium's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Equillium's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | (2.16) | |||
| Mean Deviation | 4.5 | |||
| Coefficient Of Variation | (741.79) | |||
| Standard Deviation | 6.44 | |||
| Variance | 41.45 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (0.91) | |||
| Total Risk Alpha | (1.56) | |||
| Treynor Ratio | (2.17) | |||
| Maximum Drawdown | 34.94 | |||
| Value At Risk | (11.25) | |||
| Potential Upside | 6.85 | |||
| Skewness | (1.56) | |||
| Kurtosis | 4.49 |
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | (2.16) | |||
| Mean Deviation | 4.5 | |||
| Coefficient Of Variation | (741.79) | |||
| Standard Deviation | 6.44 | |||
| Variance | 41.45 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (0.91) | |||
| Total Risk Alpha | (1.56) | |||
| Treynor Ratio | (2.17) | |||
| Maximum Drawdown | 34.94 | |||
| Value At Risk | (11.25) | |||
| Potential Upside | 6.85 | |||
| Skewness | (1.56) | |||
| Kurtosis | 4.49 |
Consider Equillium's intraday indicators
Equillium intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Equillium stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Equillium time-series forecasting models is one of many Equillium's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Equillium's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Equillium Stock media impact
Far too much social signal, news, headlines, and media speculation about Equillium that are available to investors today. That information is available publicly through Equillium media outlets and privately through word of mouth or via Equillium internal channels. However, regardless of the origin, that massive amount of Equillium data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Equillium news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Equillium relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Equillium's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Equillium alpha.
Equillium Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Equillium can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Equillium Corporate Management
| Jason Keyes | Chief Officer | Profile | |
| Matthew Ritter | Senior Development | Profile | |
| Penny Tom | Principal Officer | Profile | |
| Maple MD | Chief Officer | Profile | |
| Krishna MD | Consultant | Profile |
Additional Tools for Equillium Stock Analysis
When running Equillium's price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.